GlassScriptPhysician profile
Marieflor Bocado
NPI 1215498696
$8,962.96
in general payments reported to CMS, 2019-2025
14 companies · $4,784 in 2025
The $4,784 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $426 · 2022: $1,852 · 2023: $942 · 2024: $958 · 2025: $4,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,464 · Travel and Lodging: $2,196 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,463.86 |
| Travel and Lodging | $2,195.65 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,066.24 | 2022-2025 | Supera, Perclose Prostyle, Cardiomems |
| Boston Scientific Corporation | $3,371.63 | 2021-2025 | Watchman, Farapulse, General - Ep |
| Biotronik INC. | $349.81 | 2021-2022 | |
| Abiomed | $225.04 | 2021-2025 | |
| Amgen INC. | $221.11 | 2022-2025 | Repatha |
| Impulse Dynamics (USA) INC. | $145.40 | 2024 | Optimizer |
| Medtronic, INC. | $142.96 | 2022 | |
| Shockwave Medical, INC | $139.02 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $123.78 | 2023 | Xarelto |
| Cardiva Medical, INC. | $84.57 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.36 | 2025 | Lifevest |
| Cardiovascular Systems INC. | $28.36 | 2021 | |
| Ge Healthcare | $18.81 | 2025 | |
| Lantheus Medical Imaging, INC. | $16.87 | 2023 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marieflor Bocado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.